Healthcare -
Biotechnology - NASDAQ - US
$ 29.14
-14.7 %
$ 3.76 B
Market Cap
-7.69
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Vaxcyte, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 570 M |
| Operating Income | -570 M |
| Other Expenses | -106 M |
| Net Income | -464 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 75.0 | 9.2 | 1.8 | 1.4 | 1.2 | 1.0 | 0 |
| Gross Profit | 0 | (75.0) | (9.2) | (1.8) | (1.4) | (1.2) | (1.0) | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 569.5 | 468.0 | 207.3 | 102.1 | 87.1 | 53.9 | 35.5 | 17.4 |
| Selling, General and Administrative Expenses | 92.9 | 60.7 | 39.8 | 25.3 | 16.0 | 8.5 | 5.4 | 5.0 |
| Research and Development Expenses | 476.6 | 332.3 | 169.5 | 78.4 | 73.6 | 45.6 | 30.1 | 12.8 |
| Operating Income | (569.5) | (468.0) | (232.3) | (103.7) | (89.6) | (54.2) | (35.5) | (17.8) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0 | 2 K | 7 K | 7 K | 40 K | 75 K | 0 |
| Total Other Income | 105.6 | 65.8 | 8.8 | 3.6 | 0.4 | 3.9 | 6.0 | 0.6 |
| Pre-Tax Income | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.3) | (29.5) | (17.2) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 0 | 16.2 | 7 K | (1.4) | 3.2 | 6.1 | 0 |
| Net Income | (463.9) | (402.3) | (239.6) | (100.1) | (87.8) | (53.5) | (29.5) | (17.2) |
| EPS | 3.8 | 4.14 | 3.69 | 1.93 | 2.97 | 14.1 | 8.12 | 4.84 |